The role of genetic testing in soft tissue sarcoma

Histopathology

Volumn 48, Issue 1, 2006, Pages 13-21

  Antonescu, C R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chromosomal translocation; FISH; Genetics; RT PCR; Sarcoma

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

CARCINOGENESIS; CHEMOTHERAPY; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE FUSION; GENE MUTATION; GENETIC DISORDER; GENETIC PROCEDURES; GENETIC TRANSCRIPTION; HUMAN; KARYOTYPING; MOLECULAR BIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SOFT TISSUE SARCOMA; SOFT TISSUE TUMOR;

BASE SEQUENCE; GENETIC SCREENING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MUTATION; PROGNOSIS; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 33645083214     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02285.x     Document Type: Review

References (81)

1. Bonin S Petrera F Rosai J Stanta G DNA and RNA obtained from Bouin's fixed tissues JClinPathol 2005 58 313 316
2. Hill DA Pfeifer JD Marley EF et al. WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor. An immunohistochemical and molecular diagnostic study AmJClinPathol 2000 114 345 353
3. Cook JR Dehner LP Collins MH et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study AmJSurgPathol 2001 25 1364 1371
4. Cessna MH Zhou H Sanger WG et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases ModPathol 2002 15 931 938
5. Mitelman F Johansson B Mertens F eds Mitelman Database of Chromosome Aberrations in Cancer 2005
6. Rabbitts TH Chromosomal translocations in human cancer Nature 1994 372 143 149
7. Rabbitts TH Perspective: chromosomal translocations can affect genes controlling gene expression and differentiation - why are these functions targeted? JPathol 1999 187 39 42
8. Schlessinger J Cell signaling by receptor tyrosine kinases Cell 2002 103 211 225
9. Knezevich SR McFadden DE Tao W Lim JF Sorensen PH A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma NatGenet 1998 18 184 187
10. Bourgeois JM Knezevich SR Mathers JA Sorensen PH Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors AmJSurgPathol 2000 24 937 946
11. Simon MP Pedeutour F Sirvent N et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma NatGenet 1997 15 95 98
12. Antonescu CR Tschernyavsky SJ Decuseara R et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases ClinCancer Res 2001 7 3977 3987
13. Waters BL Panagopoulos I Allen EF Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11 Cancer GenetCytogenet 2000 121 109 116
14. Raddaoui E Donner LR Panagopoulos I Fusion of the FUS and ATF1 genes in a large, deep-seated angiomatoid fibrous histiocytoma DiagnMolPathol 2002 11 157 162
15. Fletcher CD Unni KK Mertens F eds. World Health Organization classification of tumours: pathology and genetics of tumours of soft tissue and bone
16. Enzinger FM Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm Cancer 1979 44 2147 2157
17. Parham DM Dias P Kelly DR Rutledge JC Houghton P Desmin positivity in primitive neuroectodermal tumors of childhood AmJSurgPathol 1992 16 483 492
18. Mertens F Fletcher CD Antonescu CR et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene LabInvest 2005 85 408 415
19. Gisselsson D Hibbard MK Dal Cin P et al. PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms AmJPathol 2001 159 955 962
20. Gu M Antonescu CR Guiter G Huvos AG Ladanyi M Zakowski MF Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies AmJSurgPathol 2000 24 410 416
21. Antonescu CR Argani P Erlandson RA Healey JH Ladanyi M Huvos AG Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study Cancer 1998 83 1504 1521
22. Achten R Debiec-Rychter M De Wever I Sciot R An unusual case of clear cell sarcoma arising in the jejunum highlights the diagnostic value of molecular genetic techniques in establishing a correct diagnosis Histopathology 2005 46 472 474
23. Argani P Faria PA Epstein JI et al. Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney AmJSurgPathol 2000 24 1087 1096
24. O'Sullivan MJ Kyriakos M Zhu X et al. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study ModPathol 2000 13 1336 1346
25. Guillou L Coindre J Gallagher G et al. Detection of the synovial sarcoma translocation t(X;18)(SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives HumPathol 2001 32 105 112
26. Coindre JM Hostein I Benhattar J Lussan C Rivel J Guillou L Malignant peripheral nerve sheath tumors are t(X;18)-negative sarcomas. Molecular analysis of 25 cases occurring in neurofibromatosis type 1 patients, using two different RT-PCR-based methods of detection ModPathol 2002 15 589 592
27. Ladanyi M Woodruff JM Scheithauer BW et al. Re. O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study ModPathol 2001 14 733 737
28. Pfeifer JD Hill DA O'Sullivan MJ Dehner LP Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? Histopathology 2000 37 485 500
29. Sandberg AA "SHOW ME". Eliza Doolittle in My Fair Lady Cancer GenetCytogenet 2001 128 93 96
30. Sorensen PH Lynch JC Qualman SJ et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group JClinOncol 2002 20 2672 2679
31. de Alava E Kawai A Healey JH et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma JClinOncol 1998 16 1248 1255
32. Davis RJ D'Cruz CM Lovell MA Biegel JA Barr FG Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma Cancer Res 1994 54 2869 2872
33. Ladanyi M Antonescu CR Leung DH et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients Cancer Res 2002 62 135 140
34. Guillou L Benhattar J Bonichon F et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis JClinOncol 2004 22 4040 4050
35. Oliveira AM Fletcher CD Molecular prognostication for soft tissue sarcomas: are we ready yet? JClinOncol 2004 22 4031 4034
36. Rabbitts TH Stocks MR Chromosomal translocation products engender new intracellular therapeutic technologies NatMed 2003 9 383 386
37. Hirota S Isozaki K Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 1998 279 577 580
38. Antonescu CR Sommer G Sarran L et al. Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors ClinCancer Res 2003 9 3329 3337
39. Lasota J Kopczynski J Sarlomo-Rikala M et al. KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin HumPathol 2003 34 1306 1312
40. Heinrich MC Corless CL Duensing A et al. PDGFRA activating mutations in gastrointestinal stromal tumors Science 2003 299 708 710
41. Lasota J Dansonka-Mieszkowska A Sobin LH et al. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential LabInvest 2004 84 874 883
42. Prakash S Sarran L Socci N et al. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature JPediatrHematolOncol 2005 27 179 187
43. Demetri GD von Mehren M Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors NEnglJMed 2002 347 472 480
44. Debiec-Rychter M Dumez H Judson I et al. Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group EurJCancer 2004 40 689 695
45. Heinrich MC Corless CL Demetri GD et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor JClinOncol 2003 21 4342 4349
46. Medeiros F Corless CL Duensing A et al. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications AmJSurgPathol 2004 28 889 894
47. Biegel JA Zhou JY Rorke LB Stenstrom C Wainwright LM Fogelgren B Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 1999 59 74 79
48. Rousseau-Merck MF Versteege I Legrand I et al. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors Cancer Res 1999 59 3152 3156
49. Perry A Fuller CE Judkins AR Dehner LP Biegel JA INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas ModPathol 2005 18 951 958
50. Latres E Drobnjak M Pollack D et al. Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas AmJPathol 1994 145 345 355
51. Orlow I Drobnjak M Zhang ZF et al. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival JNatl Cancer Inst 1999 91 73 79
52. Montgomery E Argani P Hicks JL DeMarzo AM Meeker AK Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically AmJPathol 2004 164 1523 1529
53. Fletcher CD Dal Cin P de Wever I et al. Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP Study Group AmJPathol 1999 154 1841 1847
54. Mertens F Fletcher CD Dal Cin P et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology Genes Chromosomes Cancer 1998 22 16 25
55. Gisselsson D Hoglund M Mertens F Dal Cin P Mandahl N Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region. Metaphase fluorescence in situ hybridization reveals complex rearrangements not detected by conventional cytogenetics AmJPathol 1999 155 61 66
56. Dal Cin P Sciot R Polito P et al. Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas Histopathology 1997 31 222 225
57. Dal Cin P Kools P Sciot R et al. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors Cancer GenetCytogenet 1993 68 85 90
58. Coindre JM Hostein I Maire G et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity JPathol 2004 203 822 830
59. Hess JL Chromosomal translocations in benign tumors: the HMGI proteins AmJClinPathol 1998 109 251 261
60. Fletcher JA Pinkus GS Donovan K et al. Clonal rearrangement of chromosome band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma Cancer Res 1992 52 6224 6228
61. Fletcher JA Pinkus JL Lage JM Morton CC Pinkus GS Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polyp Genes Chromosomes Cancer 1992 5 260 263
62. Galili N Davis RJ Fredericks WJ et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma NatGenet 1993 5 230 235
63. Ladanyi M Lui MY Antonescu CR et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 Oncogene 2001 20 48 57
64. Zucman J Delattre O Desmaze C et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts NatGenet 1993 4 341 345
65. Ladanyi M Gerald W Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor Cancer Res 1994 54 2837 2840
66. Koontz JISA Nucci M Kuo FC et al. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors ProcNatl AcadSciUSA 2001 98 6348 6353
67. Delattre O Zucman J Plougastel B et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours Nature 1992 359 162 165
68. Zucman J Melot T Desmaze C et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumours EMBO J 1993 12 4481 4487
69. Jeon IS Davis JN Braun BS et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1 Oncogene 1995 10 1229 1234
70. Kaneko Y Yoshida K Handa M et al. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy Genes Chromosomes Cancer 1996 15 115 121
71. Peter M Couturier J Pacquement H et al. A new member of the ETS family fused to EWS in Ewing tumors Oncogene 1997 14 1159 1164
72. Labelle Y Zucman J Stenman G et al. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation HumMolGenet 1995 4 2219 2226
73. Sjogren H Meis-Kindblom J Kindblom LG Aman P Stenman G Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma Cancer Res 1999 59 5064 5067
74. Sjogren H Wedell B Meis-Kindblom JM Kindblom LG Stenman G Kindblom JM Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21) Cancer Res 2000 60 6832 6835
75. Lawrence B Perez-Atayde A Hibbard MK et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors AmJPathol 2000 157 377 384
76. Bridge JA Kanamori M Ma Z et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor AmJPathol 2001 159 411 415
77. Ma Z Hill DA Collins MH et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor Genes Chromosomes Cancer 2003 37 98 105
78. Crozat A Aman P Mandahl N Ron D Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma Nature 1993 363 640 644
79. Panagopoulos I Hoglund M Mertens F Mandahl N Mitelman F Aman P Fusion of the EWS and CHOP genes in myxoid liposarcoma Oncogene 1996 12 489 494
80. Crew AJ Clark J Fisher C et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma EMBO J 1995 14 2333 2340
81. Skytting B Nilsson G Brodin B et al. A novel fusion gene, SYT-SSX4, in synovial sarcoma JNatl Cancer Inst 1999 91 974 975